Easy to use emotional screening for depression in old age: comparison of the Whooley Questions with Geriatric Depression Scale (GDS-15)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031267

Enrollment

248

Registered

2023-02-08

Start date

2023-01-09

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32.9

Interventions

Group 1: Validity of the 2-item Whooley questions is examined in comparison to the GDS-15. Whooley questions and GDS-15 are collected within the first 24 hours after admission. There is no interventio

Eligibility

Sex/Gender

All

Age

70 Years to No maximum

Inclusion criteria

Inclusion criteria: geriatric multimorbidity and inpatient stay in the geriatric ward; existing consent of the patient or an authorized person.

Exclusion criteria

Exclusion criteria: Language barriers, aphasia, severe cognitive impairment (MMSE < 10/30), psychotic symptoms

Design outcomes

Primary

Measure	Time frame
Aim of this study is the validation of a diagnostic procedure. Accordingly, the sensitivity and specificity of the diagnostic tests “two-question test” and “GDS-15” are to be examined. The endpoint is collected using the two screening methods and the gold standard MADRS (diagnostic interview). The screening procedures are collected within 24 hours of admission, the MADRS is collected within 72 hours of admission.	—

Measure

Time frame

Aim of this study is the validation of a diagnostic procedure. Accordingly, the sensitivity and specificity of the diagnostic tests “two-question test” and “GDS-15” are to be examined. The endpoint is collected using the two screening methods and the gold standard MADRS (diagnostic interview). The screening procedures are collected within 24 hours of admission, the MADRS is collected within 72 hours of admission.

—

Secondary

Measure	Time frame
feasibility of both tests in patients with mild and moderate cognitive impairment	—

Countries

Germany

Contacts

Public ContactJohannes Trabert

AGAPLESION Markus Krankenhaus

johannes.trabert@agaplesion.de+496995335311

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026